Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
about
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesSoluble epoxide hydrolase: gene structure, expression and deletionSoluble epoxide hydrolase inhibition modulates vascular remodelingEpoxides and soluble epoxide hydrolase in cardiovascular physiologyInhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseInhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in ratsCardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injuryA pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmSoluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells.EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models.Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male miceEpoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology.Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.Nitric oxide: orchestrator of endothelium-dependent responses.The cytochrome P450 pathway in angiogenesis and endothelial cell biology.The Role of Astrocytes in Metabolism and Neurotoxicity of the Pyrrolizidine Alkaloid Monocrotaline, the Main Toxin of Crotalaria retusa.Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Fetal Pulmonary Circulation: An Experimental Study in Fetal Lambs.
P2860
Q24597172-6A7870D6-32C2-44A0-8615-57E9743FBEC2Q28291292-3964C11E-940B-4F7E-BBE4-8E838419BE47Q28394250-16BCB83C-3B47-4676-AB8A-9D2AC12CAFEDQ28396313-897CEC06-EA51-44E7-AA05-E992B2624663Q33652488-ECBDE441-449A-4C4B-A877-EB7272519B42Q33665713-ADA6DF09-53F7-4D3E-ABC2-FC4A273E9AFFQ33814824-CE598451-999C-4532-8638-99F1A7DF56CAQ34357126-BE40CF87-FC2C-4580-B24F-97BB68A9C116Q34588685-FF599E6C-16ED-4545-928D-B2E9F4BE80E7Q35195538-1F281427-97FE-4DB6-8528-CCA3322582E6Q35207683-FAC68FB4-4E82-42E7-8BAF-B54FC15E2879Q35816434-E23A11B0-9B7E-4337-9F7B-44DC5E155B64Q35958442-1BD28927-E85A-499A-9FED-186780158F57Q36382133-6944D40D-A325-496A-B052-FFA62DA98623Q36535579-243DD4ED-377A-4E9C-B242-F55DF5754D63Q36681141-EF6604D2-CFA6-4AFB-9D56-7862CD7347EDQ37248337-C6FCF7E3-C47C-49F0-9420-2609C069121AQ37510865-A8DDC28B-7F59-4FB9-B1C0-D97BA37E4FBFQ37538412-84D1869A-1804-455B-A97A-D1BFE5640884Q37927098-450EE386-C477-4E92-A1F7-DCDD91D9AA0EQ37947082-E4F92B56-D937-442A-94AB-E0DD9092E01DQ38033162-751CDA33-F2A9-431A-A961-256A972F1E6BQ41195471-793B5142-78D7-40F1-B9BE-732574AAF321
P2860
Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@ast
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@en
type
label
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@ast
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@en
prefLabel
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@ast
Inhibition of the soluble epox ...... ulmonary hypertension in rats.
@en
P2093
P2860
P50
P1476
Inhibition of the soluble epox ...... pulmonary hypertension in rats
@en
P2093
Bruce D Hammock
Christophe Morisseau
Eduardo Barbosa-Sicard
Gerd Geisslinger
Marc Revermann
P2860
P304
P356
10.1097/HJH.0B013E32831AEDFA
P577
2009-02-01T00:00:00Z